16 December 2016
The first of a series of launch events for the EPSRC Grand Challenge Network+ in Proton Therapy took place in Manchester this week.
15 December 2016
Manchester is set to receive a major cash injection from Cancer Research UK.
18 November 2016
Manchester’s specialist cancer hospital The Christie NHS Foundation Trust has been rated outstanding by the health watchdog who called it ‘exceptional’ and ‘a leader in its field’.
12 October 2016
The MR-guided linear accelerator will be one of only seven in the world. It combines magnetic resonance imaging (MRI) scanning and tumour-busting radiotherapy treatment in one hi-tech package.
11 October 2016
A team of international scientists has outlined key recommendations for a global standard for scanning biomarkers in cancer - to bridge the gap between research and the clinic.
28 September 2016
The NHS could save £44 million a year in treatment costs if four cancers were diagnosed more quickly, according to cancer experts at the launch of a dedicated prevention and early detection (PED) research initiative in Manchester.
22 September 2016
One of the most advanced pieces of equipment for the UK’s first NHS high energy proton beam therapy (PBT) centre has been built for The Christie in Manchester, and will be installed in June 2017.
14 September 2016
A single Manchester bid has been awarded £28.5m from the NIHR, bringing lifesaving tests and treatments a step nearer for millions of people.
04 September 2016
Patients with non-small cell lung cancer which has spread to the brain could be spared whole brain radiotherapy as it makes little or no difference to how long they survive and their quality of life according to a Cancer Research UK-funded clinical trial.
31 August 2016
Scientists in Manchester have developed a fish-based laboratory model to better understand the genetic faults that lead to melanoma of the eye.
17 August 2016
Researchers at The University of Manchester have unlocked the potential of a new test which could revolutionise the way doctors diagnose and monitor a common childhood Leukaemia.
16 August 2016
Manchester scientists have explained some of the contradictory behaviour of a molecule known as Rac1 by showing that its activity depends on where its ‘push’ comes from.
04 August 2016
Cancer patients, scientists and fashion designers have worked together to create an intriguing exhibition with a difference, which has been on display in Manchester as part of European City of Science.
04 August 2016
The University of Manchester is to lead a £1.47million Cancer Research UK programme to bring major advances in lung cancer treatments – the North West’s most common cancer.
01 August 2016
Researchers in Manchester have shown that a pair of proteins involved in the development of blood cells may have different roles to play, with one apparently much more implicated in certain types of leukaemia.
27 July 2016
The Christie NHS Foundation Trust and University College London Hospitals NHS Foundation Trust (UCLH) together with Marketing Manchester, are delighted to be awarded the opportunity to host to prestigious Particle Therapy Co-Operative Group Annual Congress (PTCOG) in 2019, in Manchester.
26 July 2016
A new study involving researchers from The University of Manchester looked at the genetic information of more than 1,500 prostate cancer patients and identified two variants linked to increased risk of radiotherapy side-effects.
29 June 2016
Cancer Research UK researchers and the US government’s National Cancer Institute have announced that two teams will work together to radically accelerate progress against cancer, in one of the first international collaborations inspired by US Vice-President Joe Biden’s Cancer Moonshot.
15 June 2016
The University has opened the multi-million pound Stoller Biomarker Discovery Centre.
08 June 2016
New research, by the Universities of Glasgow and Manchester, has revealed an ‘Achilles heel’ of Chronic Myeloid Leukaemia (CML) and found drugs to successfully target this weakness and eradicate the disease in mice.
06 June 2016
A University of Manchester-led trial has found that having radiotherapy once a day for six and a half weeks or twice a day for three weeks – when combined with chemotherapy – is equally good at treating small cell lung cancer that hasn’t spread.
13 May 2016
Manchester scientists will play a key role in ground-breaking research into the final stages of cancer.
22 March 2016
Research in Manchester has identified mutations in lung cancer that are key to tumour growth, offering a new way to differentiate and treat some patients with the disease.
14 March 2016
An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment.
11 March 2016
Approximately a quarter of women with HER2 positive breast cancer, who were treated with a combination of the targeted drugs lapatinib and trastuzumab before surgery and chemotherapy, saw their tumours shrink significantly or even disappear, according to results from a clinical trial.
09 March 2016
The pioneering TARGET study has completed its first phase with encouraging results for conducting virtual biopsies.
07 March 2016
A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing.
08 September 2015
AstraZeneca and The University of Manchester today announced a collaboration harnessing clinical bioinformatics to deliver personalised healthcare for cancer patients.
27 July 2015
Scientists in Manchester have developed a robust blood test to identify key molecules that help tumour cells produce energy, thereby supporting cancer growth.
04 June 2015
One of the world's leading experts in radiotherapy, Marcel van Herk, has joined The Christie and The University of Manchester to lead cutting edge radiotherapy research.
14 May 2015
The Christie NHS Foundation Trust and The University of Manchester have jointly appointed a Strategic Director in experimental cancer medicine as part of a senior academic recruitment drive.
21 April 2015
Scientists from the Cancer Research UK Manchester Institute will participate in CANCER-ID, an international project to validate blood-based biomarkers for cancer.
12 January 2015
Manchester is set to play a key role in the development of proton beam therapy in the UK with the arrival of Professor Karen Kirkby as Chair in Proton Therapy Physics.